Recent News
On May 21, 2026 the company received a proposed acquisition announcement that values Lantheus at an initial enterprise consideration reported publicly. On August 6, 2026 Lantheus released second-quarter 2026 financial results and hosted an earnings call summarizing performance and guidance. On July 24, 2026 the Centers for Medicare & Medicaid Services granted a HCPCS code for PYLARIFY TruVu with an effective date of October 1, 2026.
Technical Analysis
ADX / DI+ / DI-: ADX at 12.97 indicates no clear trend strength; both directional indicators point to bearish pressure—DI+ shows a peak-and-reversal (DI+ decreasing) while DI- shows a dip-and-reversal (DI- increasing)—which signals directional momentum favoring sellers relative to recent valuation levels.
MACD: MACD registers -0.75 with the signal line at -0.54 and a peak-and-reversal pattern; MACD below the signal line and declining signals bearish momentum and reduced upside follow-through near current prices.
MRO (Momentum/Regression Oscillator): MRO at 6.86 sits positive, indicating price sits above the model target and carries downward potential pressure toward that target if momentum stalls.
RSI: RSI near 49.18 and trending down shows fading short-term momentum and a bias away from sustained buying interest around present levels rather than oversold conditions.
Price vs Moving Averages and Bands: The close at $100.48 sits below the 20-day average ($100.91) and substantially below the 50-day average ($103.81), while remaining above the 200-day average ($80.71). Short-term EMAs (12-day and 26-day) decline and sit above price, reinforcing the near-term consolidation/downside tilt. Price sits marginally below the lower 1x Bollinger band, indicating compressed volatility with the potential for short-range mean reversion or continuation of the pullback to nearby cloud support (Ichimoku Senkou B at $95.93).
Fundamental Analysis
Earnings & Guidance Signals: Reported EPS of $1.55 beat the estimate of $1.30 by $0.25, a positive surprise of 19.23%, supporting recent operating resilience despite mixed momentum in other metrics.
Profitability: EBIT of $98,740,000 produces an EBIT margin of 25.44%, above the industry peer mean of 13.24% and above the industry peer median of 20.50%, while remaining below the industry peer high of 35.13%. Sequential dynamics show the EBIT margin declined by 40.48% quarter-over-quarter and declined 12.13% year-over-year, indicating margin compression versus the immediate prior period even as the level compares favorably to typical peers.
Revenue & Earnings Growth: Reported revenue totaled $388,180,000. YoY revenue growth reads 102.89%, while the provided revenue growth metric stands at 2.88%; sequential revenue compares poorly with a quarter-over-quarter change of -139.71%, implying strong year-on-year expansion alongside a notable sequential slowdown. Reported earnings growth registers 6.16% overall, with QoQ earnings growth down 20.81% and YoY earnings growth down 37.13%—a mixed picture of sizable annual gains offset by sequential softness.
Liquidity, Cash Flow, and Leverage: Cash and short-term investments total $593,298,000, supporting a current ratio of 3.06 and a quick ratio of 2.89, both indicating ample near-term liquidity. Free cash flow of $89,868,000 yields a free cash flow yield of 1.38%, above the industry peer mean of roughly 1.00%, though free cash flow growth shows meaningful sequential pressure. Total debt stands at $624,958,000 with debt-to-EBITDA around 5.15x; interest coverage near 20.09x suggests manageable servicing at current operating levels but the leverage multiple highlights sensitivity to operating fluctuations.
Margins & Returns: Gross margin at 62.31% and operating margin at 25.82% demonstrate durable product-level profitability. Return on equity sits near 5.72% and return on assets near 3.15%, with QoQ and YoY declines in returns consistent with the sequential margin and earnings softening noted above.
Valuation Context: Trailing P/E near 64.35 and forward P/E near 59.70, a PEG above 10, price-to-sales around 16.77 and an enterprise multiple in the 50s collectively signal elevated valuation relative to growth rates and cash return metrics. The current valuation as determined by WMDST: over-valued, reflecting stretched multiples despite solid cash reserves and high margins.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2026-06-30 |
| REPORT DATE: | 2026-08-06 |
| NEXT REPORT DATE: | 2026-11-05 |
| CASH FLOW | Begin Period Cash Flow | $ 500.3 M |
| Operating Cash Flow | $ 92.2 M | |
| Capital Expenditures | $ -2.33 M | |
| Change In Working Capital | $ 11.1 M | |
| Dividends Paid | — | |
| Cash Flow Delta | $ 94.7 M | |
| End Period Cash Flow | $ 595.0 M | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | $ 388.2 M | |
| Forward Revenue | $ 133.5 M | |
| COSTS | ||
| Cost Of Revenue | $ 146.3 M | |
| Depreciation | $ 22.6 M | |
| Depreciation and Amortization | $ 22.6 M | |
| Research and Development | $ 38.2 M | |
| Total Operating Expenses | $ 288.0 M | |
| PROFITABILITY | ||
| Gross Profit | $ 241.9 M | |
| EBITDA | $ 121.3 M | |
| EBIT | $ 98.7 M | |
| Operating Income | $ 100.2 M | |
| Interest Income | $ 6.3 M | |
| Interest Expense | $ 4.9 M | |
| Net Interest Income | $ 1.3 M | |
| Income Before Tax | $ 93.8 M | |
| Tax Provision | $ 18.8 M | |
| Tax Rate | 20.033 % | |
| Net Income | $ 75.0 M | |
| Net Income From Continuing Operations | $ 75.0 M | |
| EARNINGS | ||
| EPS Estimate | $ 1.30 | |
| EPS Actual | $ 1.55 | |
| EPS Difference | $ 0.25 | |
| EPS Surprise | 19.231 % | |
| Forward EPS | $ 1.58 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | $ 2.4 B | |
| Intangible Assets | $ 928.4 M | |
| Net Tangible Assets | $ 383.4 M | |
| Total Current Assets | $ 1.0 B | |
| Cash and Short-Term Investments | $ 593.3 M | |
| Cash | $ 593.3 M | |
| Net Receivables | $ 352.9 M | |
| Inventory | $ 57.6 M | |
| Long-Term Investments | $ 59.7 M | |
| LIABILITIES | ||
| Accounts Payable | $ 48.1 M | |
| Short-Term Debt | $ 697.0 K | |
| Total Current Liabilities | $ 335.7 M | |
| Net Debt | — | |
| Total Debt | $ 625.0 M | |
| Total Liabilities | $ 1.1 B | |
| EQUITY | ||
| Total Equity | $ 1.3 B | |
| Retained Earnings | $ 873.0 M | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | $ 20.10 | |
| Shares Outstanding | 65.265 M | |
| Revenue Per-Share | $ 5.95 | |
| VALUATION | Market Capitalization | $ 6.5 B |
| Enterprise Value | $ 6.5 B | |
| Enterprise Multiple | 53.921 | |
| Enterprise Multiple QoQ | 90.575 % | |
| Enterprise Multiple YoY | 43.947 % | |
| Enterprise Multiple IPRWA | high: 418.578 mean: 65.943 median: 55.135 LNTH: 53.921 low: -170.556 |
|
| EV/R | 16.852 | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | 1.841 | |
| Asset To Liability | 2.189 | |
| Debt To Capital | 0.323 | |
| Debt To Assets | 0.259 | |
| Debt To Assets QoQ | -2.94 % | |
| Debt To Assets YoY | -11.019 % | |
| Debt To Assets IPRWA | high: 1.174 median: 0.301 mean: 0.287 LNTH: 0.259 low: 0.018 |
|
| Debt To Equity | 0.476 | |
| Debt To Equity QoQ | -7.701 % | |
| Debt To Equity YoY | -9.685 % | |
| Debt To Equity IPRWA | high: 1.558 median: 0.565 LNTH: 0.476 mean: 0.452 low: -0.505 |
|
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | 4.963 | |
| Price To Book QoQ | 18.49 % | |
| Price To Book YoY | 23.863 % | |
| Price To Book IPRWA | high: 21.577 mean: 5.476 LNTH: 4.963 median: 2.286 low: -4.924 |
|
| Price To Earnings (P/E) | 64.354 | |
| Price To Earnings QoQ | 48.458 % | |
| Price To Earnings YoY | -9.458 % | |
| Price To Earnings IPRWA | high: 344.308 mean: 69.346 LNTH: 64.354 median: 53.373 low: -330.559 |
|
| PE/G Ratio | 10.44 | |
| Price To Sales (P/S) | 16.771 | |
| Price To Sales QoQ | 24.632 % | |
| Price To Sales YoY | 35.62 % | |
| Price To Sales IPRWA | high: 66.384 mean: 22.641 LNTH: 16.771 median: 14.212 low: 0.867 |
|
| FORWARD MULTIPLES | ||
| Forward P/E | 59.703 | |
| Forward PE/G | 9.686 | |
| Forward P/S | 48.892 | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | -13.488 | |
| ASSET & SALES | ||
| Asset Turnover Ratio | 0.163 | |
| Asset Turnover Ratio QoQ | -1.17 % | |
| Asset Turnover Ratio YoY | -10.041 % | |
| Asset Turnover Ratio IPRWA | high: 0.581 mean: 0.196 median: 0.171 LNTH: 0.163 low: 0.001 |
|
| Receivables Turnover | 1.096 | |
| Receivables Turnover Ratio QoQ | 3.71 % | |
| Receivables Turnover Ratio YoY | -0.684 % | |
| Receivables Turnover Ratio IPRWA | high: 3.342 mean: 1.624 median: 1.509 LNTH: 1.096 low: 0.261 |
|
| Inventory Turnover | 2.462 | |
| Inventory Turnover Ratio QoQ | 5.929 % | |
| Inventory Turnover Ratio YoY | 17.911 % | |
| Inventory Turnover Ratio IPRWA | LNTH: 2.462 high: 2.095 mean: 0.807 median: 0.699 low: 0.055 |
|
| Days Sales Outstanding (DSO) | 83.28 | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 91.042 | |
| Cash Conversion Cycle Days QoQ | -5.762 % | |
| Cash Conversion Cycle Days YoY | -7.182 % | |
| Cash Conversion Cycle Days IPRWA | high: 355.423 mean: 133.016 median: 119.382 LNTH: 91.042 low: -70.443 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | 0.561 | |
| CapEx To Revenue | -0.006 | |
| CapEx To Depreciation | -0.103 | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | $ 1.9 B | |
| Net Invested Capital | $ 1.9 B | |
| Invested Capital | $ 1.9 B | |
| Net Tangible Assets | $ 383.4 M | |
| Net Working Capital | $ 691.4 M | |
| LIQUIDITY | ||
| Cash Ratio | 1.767 | |
| Current Ratio | 3.06 | |
| Current Ratio QoQ | 8.181 % | |
| Current Ratio YoY | -28.682 % | |
| Current Ratio IPRWA | high: 11.702 LNTH: 3.06 mean: 2.511 median: 2.126 low: 0.413 |
|
| Quick Ratio | 2.888 | |
| Quick Ratio QoQ | 9.23 % | |
| Quick Ratio YoY | -29.007 % | |
| Quick Ratio IPRWA | high: 11.177 LNTH: 2.888 mean: 1.984 median: 1.616 low: 0.336 |
|
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | 5.151 | |
| Cost Of Debt | 0.629 % | |
| Interest Coverage Ratio | 20.09 | |
| Interest Coverage Ratio QoQ | -39.408 % | |
| Interest Coverage Ratio YoY | -9.735 % | |
| Interest Coverage Ratio IPRWA | high: 70.269 LNTH: 20.09 median: 11.42 mean: 4.913 low: -88.121 |
|
| Operating Cash Flow Ratio | 0.317 | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | 29.288 | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | 2.901 % | |
| Revenue Growth | 2.875 % | |
| Revenue Growth QoQ | -139.71 % | |
| Revenue Growth YoY | 102.893 % | |
| Revenue Growth IPRWA | high: 28.183 % median: 8.761 % mean: 8.532 % LNTH: 2.875 % low: -6.025 % |
|
| Earnings Growth | 6.164 % | |
| Earnings Growth QoQ | -20.812 % | |
| Earnings Growth YoY | -37.128 % | |
| Earnings Growth IPRWA | high: 200.0 % mean: 19.956 % median: 8.824 % LNTH: 6.164 % low: -81.25 % |
|
| MARGINS | ||
| Gross Margin | 62.305 % | |
| Gross Margin QoQ | 1.809 % | |
| Gross Margin YoY | -2.27 % | |
| Gross Margin IPRWA | high: 89.754 % median: 64.456 % LNTH: 62.305 % mean: 59.914 % low: 31.392 % |
|
| EBIT Margin | 25.437 % | |
| EBIT Margin QoQ | -40.483 % | |
| EBIT Margin YoY | -12.126 % | |
| EBIT Margin IPRWA | high: 35.132 % LNTH: 25.437 % median: 20.496 % mean: 13.237 % low: -67.441 % |
|
| Return On Sales (ROS) | 25.817 % | |
| Return On Sales QoQ | 19.784 % | |
| Return On Sales YoY | 10.95 % | |
| Return On Sales IPRWA | high: 34.98 % LNTH: 25.817 % median: 20.526 % mean: 12.936 % low: -86.026 % |
|
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ 89.9 M | |
| Free Cash Flow Yield | 1.38 % | |
| Free Cash Flow Yield QoQ | -42.524 % | |
| Free Cash Flow Yield YoY | -12.492 % | |
| Free Cash Flow Yield IPRWA | high: 7.0 % LNTH: 1.38 % median: 1.058 % mean: 0.998 % low: -8.727 % |
|
| Free Cash Growth | -26.278 % | |
| Free Cash Growth QoQ | -152.795 % | |
| Free Cash Growth YoY | 3.432 % | |
| Free Cash Growth IPRWA | high: 776.0 % mean: 34.178 % median: -9.348 % LNTH: -26.278 % low: -919.099 % |
|
| Free Cash To Net Income | 1.198 | |
| Cash Flow Margin | 27.413 % | |
| Cash Flow To Earnings | 1.418 | |
| VALUE & RETURNS | ||
| Economic Value Added | $ 0.04 | |
| Return On Assets (ROA) | 3.152 % | |
| Return On Assets QoQ | -39.127 % | |
| Return On Assets YoY | -16.525 % | |
| Return On Assets IPRWA | high: 10.633 % LNTH: 3.152 % mean: 1.88 % median: 1.348 % low: -18.798 % |
|
| Return On Capital Employed (ROCE) | 4.749 % | |
| Return On Equity (ROE) | 0.057 | |
| Return On Equity QoQ | -41.441 % | |
| Return On Equity YoY | -15.259 % | |
| Return On Equity IPRWA | high: 0.539 mean: 0.063 LNTH: 0.057 median: 0.025 low: -0.544 |
|
| DuPont ROE | 5.945 % | |
| Return On Invested Capital (ROIC) | 4.194 % | |
| Return On Invested Capital QoQ | -38.765 % | |
| Return On Invested Capital YoY | -11.78 % | |
| Return On Invested Capital IPRWA | high: 13.429 % LNTH: 4.194 % mean: 2.98 % median: 1.784 % low: -12.224 % |
|